FR1478M - Médicament reconstituant et antianémique a base de panthoténate d'hydroxocobalamine. - Google Patents

Médicament reconstituant et antianémique a base de panthoténate d'hydroxocobalamine.

Info

Publication number
FR1478M
FR1478M FR868236A FR868236A FR1478M FR 1478 M FR1478 M FR 1478M FR 868236 A FR868236 A FR 868236A FR 868236 A FR868236 A FR 868236A FR 1478 M FR1478 M FR 1478M
Authority
FR
France
Prior art keywords
panthotenate
hydroxocobalamin
reconstructive
drug based
anemic drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR868236A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ROLLAND LAB A
Laboratoires Albert Rolland SA
Original Assignee
ROLLAND LAB A
Laboratoires Albert Rolland SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ROLLAND LAB A, Laboratoires Albert Rolland SA filed Critical ROLLAND LAB A
Priority to FR868236A priority Critical patent/FR1478M/fr
Priority to GB27111/62A priority patent/GB1012222A/en
Application granted granted Critical
Publication of FR1478M publication Critical patent/FR1478M/fr
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR868236A 1961-07-18 1961-07-18 Médicament reconstituant et antianémique a base de panthoténate d'hydroxocobalamine. Active FR1478M (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR868236A FR1478M (fr) 1961-07-18 1961-07-18 Médicament reconstituant et antianémique a base de panthoténate d'hydroxocobalamine.
GB27111/62A GB1012222A (en) 1961-07-18 1962-07-13 Improvements in and relating to tonic and anti-anaemic medicaments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR868236A FR1478M (fr) 1961-07-18 1961-07-18 Médicament reconstituant et antianémique a base de panthoténate d'hydroxocobalamine.

Publications (1)

Publication Number Publication Date
FR1478M true FR1478M (fr) 1962-09-10

Family

ID=8759522

Family Applications (1)

Application Number Title Priority Date Filing Date
FR868236A Active FR1478M (fr) 1961-07-18 1961-07-18 Médicament reconstituant et antianémique a base de panthoténate d'hydroxocobalamine.

Country Status (2)

Country Link
FR (1) FR1478M (fr)
GB (1) GB1012222A (fr)

Also Published As

Publication number Publication date
GB1012222A (en) 1965-12-08

Similar Documents

Publication Publication Date Title
CH390814A (fr) Dispositif de production d'aérosols
FR1538M (fr) Médicaments a base de pipérazine.
FR2227M (fr) Médicament anticoagulant a base d'heparine.
FR1038M (fr) Médicament a base d'aspirine.
FR2094M (fr) Médicament a base d'un nouvel hendécapeptide.
FR1891M (fr) Médicament a base d'un phénoxy-alcane.
FR1048M (fr) Médicament a base de streptokinase pure et apyrogene.
FR1827M (fr) Médicament a base de 1.5-benzo-dioxépannes.
FR1479M (fr) Médicament cicatrisant et antianémique a base de biotinate d'hydroxocobalamine.
BE614059A (fr) Dispositif de coupe et d'emboutissage.
FR1432M (fr) Médicament détoxicant et antianémique a base de nicotinate d'hydroxocobalamine.
FR2410M (fr) Médicament a base de dérivé de l'oxazine.
FR2231M (fr) Médicament a base de nouvelles dibenzothiéphinnes.
FR3323M (fr) Médicament a base de dérivé de l'aza-thiaxanthene.
FR2415M (fr) Médicament a base d'éthanolamines substituées.
FR2860M (fr) Médicament antiviral a base d'interféron.
FR1325925A (fr) Dispositif d'identification de caractères
FR2992M (fr) Médicament a base de 2.4-diamino-6-hydroxyméthyl-7.8-dihydro-ptéridine.
FR2721M (fr) Médicament a base de dicarbamates d'haloalkyl-1,3-propanediols.
FR3565M (fr) Médicament a base d'un nonapeptide-amide cyclique.
FR2093M (fr) Médicament a base de dérivé d'hydroxy-dibenzocycloheptane.
FR2206M (fr) Médicament a base de 2.4.7-triamino ptéridine.
FR2877M (fr) Médicament a base d'amides.
FR1987M (fr) Médicament antilipémique a base d'héparine modifiée.
FR3033M (fr) Médicaments a base de sulfapyridines.